Back to Trades
Androski Lindsay
President and CEODirectorCIK 0001936604
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Androski Lindsay, President and CEO, Director, has filed 2 SEC reports (2026), all concentrated in Arbutus Biopharma Corp (ABUS), totaling $1.3M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Sep 23 | ABUS Arbutus Biopharma Corp | Androski Lindsay | President and CEO, Director | Exercise | $1.3M |
| Feb 2 | ABUS Arbutus Biopharma Corp | Androski Lindsay | President and CEO, Director | Grant | $0 |
2 filings